MedPath

Study on the effect of oligofructose-enriched inulin in type 2 diabetes

Not Applicable
Conditions
Type 2 Diabetes Mellitus.
Non-insulin-dependent diabetes mellitus
Registration Number
IRCT201203103565N4
Lead Sponsor
Faculty Of Medicine, Tabriz University Of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
44
Inclusion Criteria

age 30-65 years old, having diabetes at least 6 months prior to the study, consumption of blood glucose lowering drug,. typical ?ber intake <25 g ?ber/d and inulin fructans intake =200 g ?ber/d.
Exclusion criteria: consumption of antioxidants supplements during last 3 months prior to the study, using insulin, pregnancy, lactation, acute renal disease,liver disease,hyperthyroidism and hypothyroidism,heart disease

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
CD4/CD8?CD3?CD4?CD8?CD11b. Timepoint: Baseline,The end of the second month. Method of measurement: Flow cytometry.;IFN-?,IL12. Timepoint: Baseline,The end of the second month. Method of measurement: Elisa.;IL4. Timepoint: Baseline,The end of the second month. Method of measurement: Elisa.
Secondary Outcome Measures
NameTimeMethod
Weight,height,BMI,WHR,WC. Timepoint: Baseline,The end of second month. Method of measurement: Antropometric Methods.;TC?TG?HDL?LDL. Timepoint: Baseline,The end of second month. Method of measurement: calorimetric.;FBS,HbA1C. Timepoint: Baseline,The end of second month. Method of measurement: calorimetric.;Blood pressure. Timepoint: Baseline,The end of second month. Method of measurement: Mercury pressure measurement.
© Copyright 2025. All Rights Reserved by MedPath